• LAST PRICE
    3.1100
  • TODAY'S CHANGE (%)
    Trending Down-0.2400 (-7.1642%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    3.1200 / 3.3500
  • Day Range
    Low 3.1100
    High 3.1200
  • 52 Week Range
    Low 2.7550
    High 10.5100
  • Volume
    1,391
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 3.35
TimeVolumeIDXG
12:57 ET12003.11
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIDXG
Interpace Biosciences Inc
14.2M
-0.9x
---
United StatesPGNY
Progyny Inc
2.7B
53.5x
---
United StatesALHC
Alignment Healthcare Inc
2.1B
-11.1x
---
United StatesMOH
Molina Healthcare Inc
16.0B
23.9x
+64.68%
United StatesHUM
Humana Inc
58.5B
19.9x
+40.99%
United StatesCNC
Centene Corp
49.3B
33.7x
+6.00%
As of 2022-06-30

Company Information

Interpace Biosciences, Inc. enables precision medicine principally in oncology by offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications through its clinical and pharma services. The Company’s clinical services provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating the risk of cancer in personalized medicine for improved patient diagnosis and management. Through its pharma services, it develops, commercializes and provides molecular and biomarker-based tests and services. Its pharma services provide pharmacogenomics testing, genotyping, biorepository and other specialized services to the pharmaceutical and biotech industries and advance personalized medicine. The Company has five commercialized molecular diagnostic tests in the marketplace, which include PancraGEN, PanDNA, ThyGeNEXT, ThyraMIR and RespriDx. Its pipeline product includes BarreGEN.

Contact Information

Headquarters
Morris Corporate Center 1 , Building C, 300 Interpace ParkwayPARSIPPANY, NJ, United States 07054
Phone
412-224-6100
Fax
302-636-5454

Executives

President, Chief Executive Officer, Director
Thomas Burnell
Chief Financial Officer, Treasurer, Secretary
Thomas Freeburg
Director
Robert Gorman
Independent Director
Vijay Aggarwal
Independent Director
Edward Chan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$14.2M
Revenue (TTM)
$41.9M
Shares Outstanding
4.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.25
EPS
$-3.29
Book Value
$0.98
P/E Ratio
-0.9x
Price/Sales (TTM)
0.3
Price/Cash Flow (TTM)
---
Operating Margin
-29.19%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.